February 8, 2011

Tacrolimus Once Daily (ADVAGRAF) Versus Twice Daily (PROGRAF) in De Novo Renal Transplantation: A Randomized Phase III Study

.   .   

Advagraf is a once daily version of tacrolimus. This was randomized controlled non-inferiority trial comparing Advagraf to standard twice-daily tacrolimus. Patient and graft survival were not significantly different between the two groups. However, the difference in acute rejection episodes (higher with Advagraf) did not meet the non-inferiority threshold.

Related Articles:

Renal Transplantation
  • Ggakadiamond

    For some reason I dont believe this: My son has been suffering severly after being force to switch over to myfordic and tacrolimus he has been suffering with not all but most of the side effects listed! So I do believe that they make a huge difference…